RANI stock news

RANI stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

11 wire items

2026-10-22 13:16:52 UTC#500253newconfirmednews

Chardan Capital maintains Buy rating on Rani Therapeutics Holdings, sets $6 price target

tradingviewimportance 0.30trust 0.60Chardan Capital Markets, LLC 0Rani Therapeutics Holdings, Inc. +0.40RaniPill +0.30

2026-10-20 18:16:21 UTC#488262newconfirmednews

Rani Therapeutics reports RT-114 Phase I PK data showing >150% bioavailability, targets 2027 obesity milestone

quartrimportance 0.40trust 0.60Rani Therapeutics Holdings, Inc. +0.40RT-114 +0.40

2026-10-05 12:00:00 UTC#413278duplicateconfirmednews

Rani Therapeutics' RaniPill platform accepted into FDA Emerging Technology Program

tradingviewimportance 0.30trust 0.70Rani Therapeutics Holdings, Inc. +0.40Food and Drug Administration +0.40RaniPill +0.40+2 entities

2026-10-05 12:00:00 UTC#413260newconfirmedpress release

Rani Therapeutics' RaniPill platform accepted into U.S. FDA Emerging Technology Program

globenewswireimportance 0.40trust 0.90Rani Therapeutics Holdings, Inc. +0.40U.S. Food and Drug Administration +0.40RaniPill +0.40+2 entities

2026-09-14 20:54:52 UTC#310079newconfirmednews

Rani Therapeutics reports positive RT-114 clinical data and new Chugai partnership for oral delivery platform

quartrimportance 0.40trust 0.60Rani Therapeutics Holdings, Inc. +0.50Chugai Pharmaceutical Co., Ltd. +0.50RT-114 +0.50

2026-08-18 12:04:00 UTC#189398newconfirmednews

Chardan Capital initiates coverage of Rani Therapeutics (RANI) with Buy rating

dow_jonesimportance 0.30trust 0.70Rani Therapeutics Holdings, Inc. +0.40Chardan Capital Markets, LLC +0.30

2026-08-14 10:49:43 UTC#177352newconfirmednews

Rani Therapeutics (RNTX) RENEW trial enrollment ahead of schedule; $57.5M raise extends cash runway to 2028

quartrimportance 0.50trust 0.70Rani Therapeutics Holdings, Inc. +0.50LTI-03 +0.40RENEW +0.30

2026-08-13 20:36:17 UTC#174324newconfirmednews

Rani Therapeutics Q2 GAAP EPS -$0.04 beats by $0.01, Revenue $1.71M beats by $0.78M

seeking alphaimportance 0.40trust 0.80Rani Therapeutics Holdings, Inc. +0.30

2026-08-12 19:54:27 UTC#167364updateconfirmednews

Rani Therapeutics RT-114 oral biologic shows >150% bioavailability in Phase I-A; highlights $1B Chugai deal

quartrimportance 0.50trust 0.60Rani Therapeutics Holdings, Inc. +0.60Chugai Pharmaceutical Co., Ltd. +0.50ProGen +0.30+2 entities

2026-08-12 19:22:43 UTC#167245newconfirmednews

Rani Therapeutics reports positive oral biologics clinical data and funding runway through late 2027

quartrimportance 0.40trust 0.60Rani Therapeutics Holdings, Inc. +0.60

2026-08-04 12:00:00 UTC#122901newconfirmedpress release

Rani Therapeutics appoints Michelle Gilson to board of directors

dow_jonesimportance 0.30trust 0.90Rani Therapeutics Holdings, Inc. +0.10Michelle Gilson +0.10